Postpartum Spinal Cord Infarction: A Case Report and Review of the Literature
Abstract
:1. Introduction
2. Case Description
Review of the Literature
3. Discussion
3.1. Incidence of Postpartum Stroke and Postpartum Spinal Cord Infarction
3.2. Etiologies of Spinal Cord Infarction
3.3. Characteristics of Our Postpartum Spinal Cord Infarction Case
3.4. Limitations
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Zalewski, N.L.; Flanagan, E.P.; Keegan, B.M. Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses. Neurology 2018, 90, e96–e102. [Google Scholar] [CrossRef]
- Novy, J.; Carruzzo, A.; Maeder, P.; Bogousslavsky, J. Spinal cord ischemia: Clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch. Neurol. 2006, 63, 1113–1120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vargas, M.I.; Gariani, J.; Sztajzel, R.; Barnaure-Nachbar, I.; Delattre, B.M.; Lovblad, K.O.; Dietemann, J.L. Spinal cord ischemia: Practical imaging tips, pearls, and pitfalls. AJNR Am. J. Neuroradiol. 2015, 36, 825–830. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garg, R.K.; Paliwal, V.K.; Gupta, A. Spinal cord involvement in COVID-19: A review. J. Spinal Cord Med. 2021, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Dunn, D.W.; Ellison, J. Anterior spinal artery syndrome during the postpartum period. Arch. Neurol. 1981, 38, 263. [Google Scholar] [CrossRef]
- Soda, T.; Shimizu, I.; Takagaki, M.; Yamada, K.; Dehara, M.; Teramoto, Y.; Moriuchi, S. A case of benign postpartum anterior spinal artery syndrome with thrombocytosis and high fibrolytic activity. Brain Nerve 2011, 63, 1125–1129. [Google Scholar]
- Katsuragi, S.; Suzuki, R.; Toyoda, K.; Neki, R.; Miyamoto, S.; Iihara, K.; Takahashi, J.; Ikeda, T.; Yoshimatsu, J. Stroke during pregnancy and puerperium among Japanese women: A single-center registry. J. Matern. Fetal Neonatal Med. 2021, 34, 2957–2964. [Google Scholar] [CrossRef]
- Khan, M.; Wasay, M.; Menon, B.; Saadatnia, M.; Venketasubramanian, N.; Gunaratne, P.; Mehndiratta, M.M.; Dai, A.; Kaul, S. Pregnancy and puerperium-related strokes in Asian women. J. Stroke Cerebrovasc. Dis. 2013, 22, 1393–1398. [Google Scholar] [CrossRef]
- Mas, J.L.; Lamy, C. Stroke in pregnancy and the puerperium. J. Neurol. 1998, 245, 305–313. [Google Scholar] [CrossRef]
- Kittner, S.J.; Stern, B.J.; Feeser, B.R.; Hebel, R.; Nagey, D.A.; Buchholz, D.W.; Earley, C.J.; Johnson, C.J.; Macko, R.F.; Sloan, M.A.; et al. Pregnancy and the risk of stroke. N. Engl. J. Med. 1996, 335, 768–774. [Google Scholar] [CrossRef] [Green Version]
- Sharshar, T.; Lamy, C.; Mas, J.L. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995, 26, 930–936. [Google Scholar] [CrossRef]
- Karjalainen, L.; Tikkanen, M.; Rantanen, K.; Aarnio, K.; Korhonen, A.; Saaros, A.; Laivuori, H.; Gissler, M.; Ijas, P. Stroke in Pregnancy and Puerperium: Validated Incidence Trends with Risk Factor Analysis in Finland 1987–2016. Neurology 2021, 96, e2564–e2575. [Google Scholar] [CrossRef] [PubMed]
- Elgendy, I.Y.; Gad, M.M.; Mahmoud, A.N.; Keeley, E.C.; Pepine, C.J. Acute Stroke During Pregnancy and Puerperium. J. Am. Coll. Cardiol. 2020, 75, 180–190. [Google Scholar] [CrossRef] [PubMed]
- Masson, C.; Pruvo, J.P.; Meder, J.F.; Cordonnier, C.; Touze, E.; De La Sayette, V.; Giroud, M.; Mas, J.L.; Leys, D.; Study Group on Spinal Cord Infarction of the French Neurovascular Society. Spinal cord infarction: Clinical and magnetic resonance imaging findings and short term outcome. J. Neurol. Neurosurg. Psychiatry 2004, 75, 1431–1435. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Weidauer, S.; Nichtweiss, M.; Hattingen, E.; Berkefeld, J. Spinal cord ischemia: Aetiology, clinical syndromes and imaging features. Neuroradiology 2015, 57, 241–257. [Google Scholar] [CrossRef]
- Hsu, J.L.; Cheng, M.Y.; Liao, M.F.; Hsu, H.C.; Weng, Y.C.; Chang, K.H.; Chang, H.S.; Kuo, H.C.; Huang, C.C.; Lyu, R.K.; et al. The etiologies and prognosis associated with spinal cord infarction. Ann. Clin. Transl. Neurol. 2019, 6, 1456–1464. [Google Scholar] [CrossRef] [Green Version]
- Kobayashi, K.; Narimatsu, N.; Oyoshi, T.; Ikeda, T.; Tohya, T. Spinal cord infarction following epidural and general anesthesia: A case report. JA Clin. Rep. 2017, 3, 42. [Google Scholar] [CrossRef] [Green Version]
- de Seze, M.P.; Sztark, F.; Janvier, G.; Joseph, P.A. Severe and long-lasting complications of the nerve root and spinal cord after central neuraxial blockade. Anesth. Analg. 2007, 104, 975–979. [Google Scholar] [CrossRef]
- Fernandez, M.F.; Dachy, B.; Demeurisse, G. Lower limb monoplegia and dissociated hypoesthesia after peridural anesthesia. Rev. Neurol. 1999, 155, 598–600. [Google Scholar]
- Weinberg, L.; Harvey, W.R.; Marshall, R.J. Post-operative paraplegia following spinal cord infarction. Acta Anaesthesiol. Scand. 2002, 46, 469–472. [Google Scholar] [CrossRef]
- Ackerman, W.E.; Juneja, M.M.; Knapp, R.K. Maternal paraparesis after epidural anesthesia and cesarean section. South Med. J. 1990, 83, 695–697. [Google Scholar] [CrossRef] [PubMed]
- Chernecky, C.; Berger, B. Antithrombin III (AT-III) Test-Diagnostic in Laboratory Tests and Diagnostic Procedures, 6th ed.; Elsevier Saunders: St Louis, MO, USA, 2013. [Google Scholar]
- Mannucci, P.M.; Valsecchi, C.; Bottasso, B.; D’Angelo, A.; Casati, S.; Ponticelli, C. High plasma levels of protein C activity and antigen in the nephrotic syndrome. Thromb. Haemost. 1986, 55, 31–33. [Google Scholar] [CrossRef] [PubMed]
- Rao, A.K.; Niewiarowski, S.; James, P.; Holt, J.C.; Harris, M.; Elfenbein, B.; Bastl, C. Effect of heparin on the in vivo release and clearance of human platelet factor 4. Blood 1983, 61, 1208–1214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schultz, N.H.; Sorvoll, I.H.; Michelsen, A.E.; Munthe, L.A.; Lund-Johansen, F.; Ahlen, M.T.; Wiedmann, M.; Aamodt, A.H.; Skattor, T.H.; Tjonnfjord, G.E.; et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N. Engl. J. Med. 2021, 384, 2124–2130. [Google Scholar] [CrossRef] [PubMed]
- van Kammen, M.S.; de Sousa, D.A.; Poli, S.; Cordonnier, C.; Heldner, M.R.; van de Munckhof, A.; Krzywicka, K.; van Haaps, T.; Ciccone, A.; Middeldorp, S.; et al. Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021, 78, 1314–1323. [Google Scholar] [CrossRef] [PubMed]
- Pavord, S.; Scully, M.; Hunt, B.J.; Lester, W.; Bagot, C.; Craven, B.; Rampotas, A.; Ambler, G.; Makris, M. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N. Engl. J. Med. 2021, 385, 1680–1689. [Google Scholar] [CrossRef]
- Huang, C.T.; Hsu, S.Y.; Chang, K.W.; Huang, C.G.; Yang, C.T.; Cheng, M.H. Heparin-induced thrombocytopenia and thrombosis in a patient with COVID-19. Thromb. Res. 2020, 196, 11–14. [Google Scholar] [CrossRef]
- Long, B.; Bridwell, R.; Gottlieb, M. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Am. J. Emerg. Med. 2021, 49, 58–61. [Google Scholar] [CrossRef]
- Page, D.; Zhu, N.; Sawler, D.; Sun, H.W.; Turley, E.; Pai, M.; Wu, C. Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count. Res. Pr. Thromb. Haemost. 2021, 5, e12596. [Google Scholar] [CrossRef]
- Zazzeron, L.; Rosovsky, R.P.; Bittner, E.A.; Chang, M.G. Comparison of Published Guidelines for the Diagnosis and the Management of Vaccine-Induced Immune Thrombotic Thrombocytopenia. Crit. Care Explor. 2021, 3, e0519. [Google Scholar] [CrossRef]
- World Health Organization. Guidance for Clinical Case Management of Thrombosis with Thrombocytopenia Syndrome (TTS) following Vaccination to Prevent Coronavirus Disease (COVID-19); World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
- Sangli, S.; Virani, A.; Cheronis, N.; Vannatter, B.; Minich, C.; Noronha, S.; Bhagavatula, R.; Speredelozzi, D.; Sareen, M.; Kaplan, R.B. Thrombosis with Thrombocytopenia After the Messenger RNA-1273 Vaccine. Ann. Intern. Med. 2021, 174, 1480–1482. [Google Scholar] [CrossRef] [PubMed]
- Danish, F.I.; Rabani, A.E.; Subhani, F.E.; Yasmin, S.; Koul, S.S. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia. Eur. J. Haematol. 2022. [CrossRef] [PubMed]
- Yang, H.; Qi, Y.Y.; Gong, M.F.; Zhang, S.; Zhang, D.; Wang, H.G.; Zhang, Z.F.; Wang, G.X.; Zou, L.G. CT angiography of cervical anterior spinal artery and anterior radicular artery: Preliminary study on technology and its clinical application. Clin. Imaging 2015, 39, 32–36. [Google Scholar] [CrossRef] [PubMed]
- Hino, T.; Kamitani, T.; Sagiyama, K.; Yamasaki, Y.; Matsuura, Y.; Tsutsui, S.; Sakai, Y.; Furuyama, T.; Yabuuchi, H. Detectability of the artery of Adamkiewicz on computed tomography angiography of the aorta by using ultra-high-resolution computed tomography. Jpn. J. Radiol. 2020, 38, 658–665. [Google Scholar] [CrossRef] [PubMed]
- Jones, M.; Boisvert, A.; Landry, J.; Petrasek, P.F. Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: A case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ 2021, 193, E906–E910. [Google Scholar] [CrossRef]
- Klein, N.P.; Lewis, N.; Goddard, K.; Fireman, B.; Zerbo, O.; Hanson, K.E.; Donahue, J.G.; Kharbanda, E.O.; Naleway, A.; Nelson, J.C.; et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA 2021, 326, 1390–1399. [Google Scholar] [CrossRef]
Study, Units | Dunn DW et al. Case | Soda T et al. Case | Our Case (Reference Value) |
---|---|---|---|
Polymerase chain reaction test for SARS-CoV-2 virus using a nasopharyngeal swab | NA | NA | negative (negative) |
Initial platelet count, ×109 cells/L | NA | 623 * | 222 (150–400) |
fibrinogen level, mg/mL | NA | 4.66 * | 3.21 (1.90–3.80) |
Fibrin degradation products, μg/mL | NA | 10.2 | 15.8 (<5) |
Peak D-dimer, ng/mL | NA | 5200 | 5213 (<500) |
Peak activated partial thromboplastin time, s | normal | normal | 23.4 (24.6–33.8) |
Prothrombin time, s | normal | normal | 11.1 (8–12) |
Anti-human heparin platelet factor 4 antibody, ng/mL | NA | NA | 58.89 * (<50) |
Anticardiolipin antibody level | |||
IgG GPL-U/mL | NA | NA | 5.8 (<10) |
IgM GPL-U/mL | NA | NA | 5.7 (<10) |
Protein C level, % | NA | normal | >150 * (70–140) |
Protein S level, % | NA | normal | 64 (60–140) |
Antithrombin III level, % | NA | NA | 146 * (75–125) |
Antinuclear antibodies | negative | negative | negative |
VDRL | negative | negative | negative |
Lupus anticoagulant test | NA | NA | negative (negative) |
Procalcitonin, ng/mL | NA | NA | <0.02 (<0.02) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hsu, J.-L.; Chin, S.-C.; Cheng, M.-H.; Wu, Y.-R.; Ro, A.; Ro, L.-S. Postpartum Spinal Cord Infarction: A Case Report and Review of the Literature. Medicines 2022, 9, 54. https://doi.org/10.3390/medicines9110054
Hsu J-L, Chin S-C, Cheng M-H, Wu Y-R, Ro A, Ro L-S. Postpartum Spinal Cord Infarction: A Case Report and Review of the Literature. Medicines. 2022; 9(11):54. https://doi.org/10.3390/medicines9110054
Chicago/Turabian StyleHsu, Jung-Lung, Shy-Chyi Chin, Ming-Huei Cheng, Yih-Ru Wu, Aileen Ro, and Long-Sun Ro. 2022. "Postpartum Spinal Cord Infarction: A Case Report and Review of the Literature" Medicines 9, no. 11: 54. https://doi.org/10.3390/medicines9110054
APA StyleHsu, J. -L., Chin, S. -C., Cheng, M. -H., Wu, Y. -R., Ro, A., & Ro, L. -S. (2022). Postpartum Spinal Cord Infarction: A Case Report and Review of the Literature. Medicines, 9(11), 54. https://doi.org/10.3390/medicines9110054